Immunodiagnostic Systems Holdings PLC (“the Company”), a leading producer of diagnostic testing kits, announces that on 29 January 2010, 33,361 ordinary shares of 2p each in the Company (the “Ordinary Shares”) were allotted in a board meeting to satisfy an exercise of options. Additionally, at the same board meeting 26,648 Ordinary Shares were allotted to […]
Immunodiagnostic Systems Holdings plc (“IDS”), a leading producer of diagnostic testing kits for the clinical and research markets, announces that Technogenetics s.r.l. (“Technogenetics”) of Milan, Italy has signed a five year distribution agreement with A. Menarini Diagnostics (“Menarini”) covering Europe for an automated test system, the Zenit RA, together with a panel of 21 tests […]
